Navigation Links
Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan
Date:9/6/2010

air(R) efficacy after 4 months of treatment and the persistence of its therapeutic effect after only one year of treatment (study VO57.07 conducted in Europe), Stallergenes is now preparing filing NDA in Germany. A phase III pediatric study has been launched.

The Stalair(R) r Bet v 1 tablet (birch pollen recombinant allergen) has been the subject of a positive phase IIb/III clinical trial conducted in allergic rhinitis caused by birch pollen. A confirmatory phase III study is currently being prepared with a view to EMA registration.

The ragweed pollen and Japanese cedar pollen tablets are at an early stage of development.

Altogether, the program covers 80% of the epidemiology for all markets.

ABOUT SHIONOGI & CO.,LTD

Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi's Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain, and Metabolic Syndrome. The Company is the originator of innovative medicines which have been successfully delivered to millions of patients worldwide. In addition, Shionogi is engaged in new research areas such as allergy and cancer. Contributing to the health of patients around the world through development in these therapeutic areas is Shionogi's primary goal. For more details, please visit www.shionogi.co.jp.

ABOUT STALLERGENES

Stallergenes is a European biopharmaceutical company dedicated to immunotherapy treatments for the prevention and treatment of allergy-related respiratory diseases, such as allergic rhinoconjunctivitis, rhinitis and asthma.

A pioneer and leader in sublingual immunotherapy treatments, Stallergenes dedicates more than 20% of its turnover, in gross terms, to Research and Development and is actively involved in the development of a new therapeutic class: sublingual
'/>"/>

SOURCE Stallergenes
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13%
2. STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
3. STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
4. STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations
5. STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
6. Stallergenes : Investor Meeting: Webcast is Available
7. STALLERGENES: 2008: Strong Performance
8. Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*
9. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
10. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
11. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Texas (PRWEB) December 23, 2014 ... methyl mercaptan such as its definition, classification, ... presents product specification, manufacturing process, and product ... technology and applications. The analysis also covers ... marketing channels, industry development trend and proposals. ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
(Date:12/22/2014)... December 22, 2014 The Center ... leader of technical training across the life sciences industry, ... Management (SCDM) to provide the organization's members with ... —providing access to the more than 350 sessions across ... with 10% off when registering for a public ...
(Date:12/22/2014)... , Dec. 22, 2014  ( www.competitivehealth.com ) — ... online medical bill review and advocacy service, has signed ... FREE WellCard Savings discount health services marketplace. ... was more than they expected to pay. As part ... care costs, WellCard Savings is pleased to offer medical ...
Breaking Biology Technology:Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... ... Sepha Ltd has launched a new, mobile blister packing ... minimal cost. EZ BlisterII is a compact, easy to use ... response to global demand from major pharmaceutical and clinical trial laboratories for ...
... ESA,s Envisat has captured the changes in direction of the ... winds over the weekend pushed it around and hampered clean-up ... visible due east of the Delta National Wildlife Refuge extending ... ships. ,Wind can easily spread oil on the water, with ...
... from Stevens Institute of Technology, consisting of undergraduate ... Jing, Xi Chen, and Zhenbo Fu and led ... Shi from the Department of Mechanical Engineering, placed ... Institute of Standards and Technology (NIST) Mobile Microrobotics ...
Cached Biology Technology:New Mobile Blister Packing Technology Launched by Packaging Machinery Manufacturer, Sepha Ltd 2Envisat monitoring changes in oil spill 2Stevens team places third in 2010 IEEE/NIST Mobile Microrobotics Challenge 2
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
(Date:11/21/2014)... Strict laws against distracted driving and the ... American and European automotive sector towards gesture recognition technologies. ... that are intuitive and able to retrieve information with ... New analysis from Frost & Sullivan,s Strategic ... Europe and North America ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... age was beginning to wane, often are attributed in part to ... by University of Washington researchers, an ice core of 1,000 meters ... key section of the West Antarctic Ice Sheet probably never contained ... it couldn't have contributed as much to the higher sea level. ...
... appear essential for 'hair cells',responsible for hearing and ... glia may be essential for the normal development,of ... to new,University of Utah research. The study is ... and is co-authored by scientists at the University,of ...
... led by Johns Hopkins scientists has,found the first ... immune,system's remarkable ability to recognize and respond to ... family of genes whose,only apparent function is to ... cut themselves out of the genetic material, and ...
Cached Biology News:Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 2Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 3Zebrafish may hold key to understanding human nerve cell development 2Gene sequencing explains bioremediation 'bug' 2Gene sequencing explains bioremediation 'bug' 3
... incubators with rotators. Graduated, 35 mm ... plug-seal screw-cap with O-ring for a ... to accept different size hybridization membranes. ... separately. • Comp Dim: tube L ...
... gels The SpinPrep Gel DNA Kit enables efficient ... 12,000 bp in size from agarose gels. The procedure ... by adsorption of the DNA to a silica membrane ... the purified DNA is eluted in low-salt buffer. Each ...
Fujifilm BAS-1800II provides the ideal configuration for a low-cost imager that requires only a small amount of space in the laboratory. The small imager for accurate high-throughput screening...
When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
Biology Products: